Company secures regulatory approvals for commercial rollout in UK and US
Category: News
The Board of the Medicines and Healthcare products Regulatory Agency (MHRA) has met in Scotland for the first […]
Strategic collaboration aims to improve early diagnosis
The drug was recently approved in the US for familial chylomicronaemia syndrome
Brekiya is now the first DHE auto-injector to be approved by the regulator
Regulator confirms safety and efficacy of new treatment option for patient
Biotech spin-off targets fibrosis, neoplasm and neovascularization
Aspire-FTD study aims to stop disease progression with one-time treatment
Trial progresses towards topline data expected later in the year
FDA recognises KER-0193 as a potential therapy for rare paediatric disease